| Trial ID: | L6049 |
| Source ID: | NCT04907838
|
| Associated Drug: |
Insulin Clamp
|
| Title: |
Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes
|
| Interventions: |
DRUG: Insulin clamp|DRUG: BQ123|DRUG: BQ123 + BQ788
|
| Outcome Measures: |
Primary: Glucose infusion rate, Glucose infusion rate required to maintain euglycemia during insulin clamp with and without endothelin blockade, 3.5 hours|Leg blood flow, Effect of endothelin receptor blockade on leg blood flow (ultrasound Doppler) during insulin clamp with and without endothelin blockade, 3.5 hours |
|
| Sponsor/Collaborators: |
Sponsor: University of Southern Denmark | Collaborators: The University of Texas at Arlington
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2018-05-01
|
| Completion Date: |
2021-07-30
|
| Results First Posted: |
|
| Last Update Posted: |
2021-06-01
|
| Locations: |
Cardiovascular and Renal Research, Odense, 5000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT04907838
|
